Windtree To Present at the ThinkEquity Conference on October 30th

WARRINGTON, Pa., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that Craig Fraser, Chairman and Chief Executive Officer, will be presenting a corporate update at the ThinkEquity Conference on Oct 30^th at 12:30pm ET. Windtree management will also be participating in 1x1 meetings with investors at the event.